Relationship of Hearing Loss to Parkinson’s Disease, Dementia, and APOE Genotype in Adults
Abstract
:1. Introduction
2. Materials and Methods
2.1. Patient Recruitment
2.2. Assessment Tools
2.2.1. Analyzing APOE Genotype from Peripheral-Blood Samples
2.2.2. Hearing Assessment
2.2.3. Cognitive Function Assessment
2.2.4. Staging of Parkinson’s Disease–Modified Hoehn and Yahr Scale
2.3. Statistical Analysis
3. Results
3.1. Demographic and Clinical Characteristics of Study Population
3.2. APOE Gene Expression and Dementia
3.3. APOE Gene Expression and Parkinson’s Disease Severity
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- World Health Organization, WHO. Deafness and Hearing Loss. 2020. Available online: https://www.who.int/news-room/fact-sheets/detail/deafness-and-hearing-loss (accessed on 13 March 2024).
- Kochkin, S.; Rogin, C. Quantifying the obvious: The impact of hearing instruments on quality of life. Hear. Rev. 2000, 7, 6–34. [Google Scholar]
- Lin, F.R.; Albert, M. Hearing loss and dementia—Who is listening? Aging Ment. Health 2014, 18, 671–673. [Google Scholar] [CrossRef] [PubMed]
- Lin, F.R.; Metter, E.J.; O’Brien, R.J.; Resnick, S.M.; Zonderman, A.B.; Ferrucci, L. Hearing loss and incident dementia. Arch. Neurol. 2011, 68, 214–220. [Google Scholar] [CrossRef] [PubMed]
- Lai, S.W.; Liao, K.F.; Lin, C.L.; Lin, C.C.; Sung, F.C. Hearing loss may be a non-motor feature of Parkinson’s disease in older people in Taiwan. Eur. J. Neurol. 2014, 21, 752–757. [Google Scholar] [CrossRef]
- Großmann, W. Listening with an Ageing Brain—A Cognitive Challenge. Laryngorhinootologie 2023, 102, S12–S34. [Google Scholar] [CrossRef] [PubMed]
- Levine, C.B.; Fahrbach, K.R.; Siderowf, A.D.; Estok, R.P.; Ludensky, V.M.; Ross, S.D. Diagnosis and treatment of Parkinson’s disease: A systematic review of the literature. Evid. Rep./Technol. Assess. (Summ.) 2003, 1–4. [Google Scholar]
- Betarbet, R.; Canet-Aviles, R.M.; Sherer, T.B.; Mastroberardino, P.G.; McLendon, C.; Kim, J.H.; Lund, S.; Na, H.M.; Taylor, G.; Bence, N.F.; et al. Intersecting pathways to neurodegeneration in Parkinson’s disease: Effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol. Dis. 2006, 22, 404–420. [Google Scholar] [CrossRef]
- Uhlmann, R.F.; Larson, E.B.; Rees, T.S.; Koepsell, T.D.; Duckert, L.G. Relationship of hearing impairment to dementia and cognitive dysfunction in older adults. JAMA 1989, 261, 1916–1919. [Google Scholar] [CrossRef] [PubMed]
- Kalluri, S.; Humes, L.E. Hearing technology and cognition. Am. J. Audiol. 2012, 21, 338–343. [Google Scholar] [CrossRef]
- Paternoster, L.; Martinez-Gonzalez, N.A.; Charleton, R.; Chung, M.; Lewis, S.; Sudlow, C.L. Genetic effects on carotid intima-media thickness: Systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects. Circ. Cardiovasc. Genet. 2010, 3, 15–21. [Google Scholar] [CrossRef]
- McKay, G.J.; Patterson, C.C.; Chakravarthy, U.; Dasari, S.; Klaver, C.C.; Vingerling, J.R.; Ho, L.; de Jong, P.T.; Fletcher, A.E.; Young, I.S.; et al. Evidence of association of APOE with age-related macular degeneration: A pooled analysis of 15 studies. Hum. Mutat. 2011, 32, 1407–1416. [Google Scholar] [CrossRef]
- Rasmussen, K.L.; Tybjaerg-Hansen, A.; Nordestgaard, B.G.; Frikke-Schmidt, R. APOE and dementia—Resequencing and genotyping in 105,597 individuals. Alzheimer’s Dement. 2020, 16, 1624–1637. [Google Scholar] [CrossRef] [PubMed]
- Wu, J.; Hasselgren, C.; Zettergren, A.; Zetterberg, H.; Blennow, K.; Skoog, I.; Hallerod, B. The impact of social networks and APOE epsilon4 on dementia among older adults: Tests of possible interactions. Aging Ment. Health 2020, 24, 395–404. [Google Scholar] [CrossRef]
- Morris, J.C. Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 1997, 9 (Suppl. 1), 173–176; discussion 177–178. [Google Scholar] [CrossRef]
- Mitchell, A.J. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J. Psychiatr. Res. 2009, 43, 411–431. [Google Scholar] [CrossRef] [PubMed]
- Goetz, C.G.; Poewe, W.; Rascol, O.; Sampaio, C.; Stebbins, G.T.; Counsell, C.; Giladi, N.; Holloway, R.G.; Moore, C.G.; Wenning, G.K.; et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations. Mov. Disord. 2004, 19, 1020–1028. [Google Scholar] [CrossRef] [PubMed]
- Livingston, G.; Huntley, J.; Sommerlad, A.; Ames, D.; Ballard, C.; Banerjee, S.; Brayne, C.; Burns, A.; Cohen-Mansfield, J.; Cooper, C.; et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020, 396, 413–446. [Google Scholar] [CrossRef] [PubMed]
- Liu, C.M.; Lee, C.T. Association of Hearing Loss with Dementia. JAMA Netw. Open 2019, 2, e198112. [Google Scholar] [CrossRef]
- Shetty, K.; Krishnan, S.; Thulaseedharan, J.V.; Mohan, M.; Kishore, A. Asymptomatic Hearing Impairment Frequently Occurs in Early-Onset Parkinson’s Disease. J. Mov. Disord. 2019, 12, 84–90. [Google Scholar] [CrossRef]
- Folmer, R.L.; Vachhani, J.J.; Theodoroff, S.M.; Ellinger, R.; Riggins, A. Auditory Processing Abilities of Parkinson’s Disease Patients. BioMed Res. Int. 2017, 2017, 2618587. [Google Scholar] [CrossRef]
- Vitale, C.; Marcelli, V.; Allocca, R.; Santangelo, G.; Riccardi, P.; Erro, R.; Amboni, M.; Pellecchia, M.T.; Cozzolino, A.; Longo, K.; et al. Hearing impairment in Parkinson’s disease: Expanding the nonmotor phenotype. Mov. Disord. 2012, 27, 1530–1535. [Google Scholar] [CrossRef] [PubMed]
- Shalash, A.S.; Hassan, D.M.; Elrassas, H.H.; Salama, M.M.; Méndez-Hernández, E.; Salas-Pacheco, J.M.; Arias-Carrión, O. Auditory- and Vestibular-Evoked Potentials Correlate with Motor and Non-Motor Features of Parkinson’s Disease. Front. Neurol. 2017, 8, 55. [Google Scholar] [CrossRef] [PubMed]
- Akil, O.; Weber, C.M.; Park, S.N.; Ninkina, N.; Buchman, V.; Lustig, L.R. Localization of synucleins in the mammalian cochlea. J. Assoc. Res. Otolaryngol. 2008, 9, 452–463. [Google Scholar] [CrossRef] [PubMed]
- Pisani, V.; Sisto, R.; Moleti, A.; Di Mauro, R.; Pisani, A.; Brusa, L.; Altavista, M.C.; Stanzione, P.; Di Girolamo, S. An investigation of hearing impairment in de-novo Parkinson’s disease patients: A preliminary study. Park. Relat. Disord. 2015, 21, 987–991. [Google Scholar] [CrossRef] [PubMed]
- Garasto, E.; Stefani, A.; Pierantozzi, M.; Cerroni, R.; Conti, M.; Maranesi, S.; Mercuri, N.B.; Chiaravalloti, A.; Schillaci, O.; Viziano, A.; et al. Association between hearing sensitivity and dopamine transporter availability in Parkinson’s disease. Brain Commun. 2023, 5, fcad075. [Google Scholar] [CrossRef] [PubMed]
- Pang, S.; Li, J.; Zhang, Y.; Chen, J. Meta-Analysis of the Relationship between the APOE Gene and the Onset of Parkinson’s Disease Dementia. Park. Dis. 2018, 2018, 9497147. [Google Scholar] [CrossRef]
- Real, R.; Martinez-Carrasco, A.; Reynolds, R.H.; Lawton, M.A.; Tan, M.M.X.; Shoai, M.; Corvol, J.C.; Ryten, M.; Bresner, C.; Hubbard, L.; et al. Association between the LRP1B and APOE loci and the development of Parkinson’s disease dementia. Brain 2023, 146, 1873–1887. [Google Scholar] [CrossRef]
- O’Grady, G.; Boyles, A.L.; Speer, M.; DeRuyter, F.; Strittmatter, W.; Worley, G. Apolipoprotein E alleles and sensorineural hearing loss. Int. J. Audiol. 2007, 46, 183–186. [Google Scholar] [CrossRef]
- Kurniawan, C.; Westendorp, R.G.; de Craen, A.J.; Gussekloo, J.; de Laat, J.; van Exel, E. Gene dose of apolipoprotein E and age-related hearing loss. Neurobiol. Aging 2012, 33, 2230.e7–2230.e12. [Google Scholar] [CrossRef]
- Kim, Y.Y.; Chao, J.R.; Kim, C.; Kim, B.; Thi-Thanh Nguyen, P.; Jung, H.; Chang, J.; Lee, J.H.; Suh, J.G. Hearing loss through apoptosis of the spiral ganglion neurons in apolipoprotein E knockout mice fed with a western diet. Biochem. Biophys. Res. Commun. 2020, 523, 692–698. [Google Scholar] [CrossRef]
- Wang, H.X.; Gustafson, D.R.; Kivipelto, M.; Pedersen, N.L.; Skoog, I.; Windblad, B.; Fratiglioni, L. Education halves the risk of dementia due to apolipoprotein ε4 allele: A collaborative study from the Swedish brain power initiative. Neurobiol. Aging 2012, 33, 1007.e1–1007.e7. [Google Scholar] [CrossRef] [PubMed]
- Fyfe, I. APOE(*)ε4 promotes synucleinopathy. Nat. Rev. Neurol. 2020, 16, 185. [Google Scholar] [CrossRef] [PubMed]
- Davis, A.A.; Inman, C.E.; Wargel, Z.M.; Dube, U.; Freeberg, B.M.; Galluppi, A.; Haines, J.N.; Dhavale, D.D.; Miller, R.; Choudhury, F.A.; et al. APOE genotype regulates pathology and disease progression in synucleinopathy. Sci. Transl. Med. 2020, 12, aay3069. [Google Scholar] [CrossRef] [PubMed]
- Zhao, N.; Attrebi, O.N.; Ren, Y.; Qiao, W.; Sonustun, B.; Martens, Y.A.; Meneses, A.D.; Li, F.; Shue, F.; Zheng, J.; et al. APOE4 exacerbates α-synuclein pathology and related toxicity independent of amyloid. Sci. Transl. Med. 2020, 12, eaay1809. [Google Scholar] [CrossRef] [PubMed]
- Rizzuto, D.; Fratiglioni, L. Lifestyle factors related to mortality and survival: A mini-review. Gerontology 2014, 60, 327–335. [Google Scholar] [CrossRef] [PubMed]
- Engdahl, B.; Aarhus, L. Prevalence and predictors of self-reported hearing aid use and benefit in Norway: The HUNT study. BMC Public Health 2024, 24, 474. [Google Scholar] [CrossRef] [PubMed]
- Dawes, P.; Völter, C. Do hearing loss interventions prevent dementia? Z. Gerontol. Geriatr. 2023, 56, 261–268. [Google Scholar] [CrossRef]
- Naylor, G.; Dillard, L.; Orrell, M.; Stephan, B.C.M.; Zobay, O.; Saunders, G.H. Dementia and hearing-aid use: A two-way street. Age Ageing 2022, 51, afac266. [Google Scholar] [CrossRef]
Non-Dementia Group n = 31 | Dementia Group n = 41 | p-Value | |
---|---|---|---|
Age (years) | 62.5 ± 8.9 | 71.0 ± 7.4 | <0.001 ** |
Gender | 1.000 | ||
Male | 19 | 25 | |
Woman | 12 | 16 | |
Right-hearing threshold (dB) | 31.9 ± 24.6 | 45.1 ± 24.5 | 0.025 * |
Left-hearing threshold (dB) | 31.6 ± 20.5 | 49.0 ± 25.9 | 0.002 ** |
Average hearing threshold (dB) | 31.7 ± 22.1 | 47.1 ± 24.4 | 0.006 ** |
Binaural hearing impairment (%) | 13.7 ± 25.2% | 30.0 ± 30.8% | 0.014 * |
Speech reception threshold (dB) | 27.9 ± 21.7 | 42.9 ± 27.4 | 0.011 * |
Speech discrimination ability | 91.4 ± 12.2% | 82.7 ± 24.7% | 0.075 |
Hearing | 0.002 ** | ||
Unimpaired (threshold ≤ 25 dB) | 16 | 7 | |
Impaired (>25 dB) | 15 | 34 | |
Parkinson’s disease | 0.132 | ||
No | 3 | 11 | |
Yes | 28 | 30 |
APOE ε4 Allele n = 10 | No APOE ε4 Allele n = 62 | p-Value | |
---|---|---|---|
Age (years) | 71.1 ± 5.8 | 66.7 ± 9.4 | 0.156 |
Gender | 1.000 | ||
Male | 6 | 38 | |
Woman | 4 | 24 | |
Right-hearing threshold (dB) | 48.6 ± 24.3 | 38.4 ± 25.6 | 0.240 |
Left-hearing threshold (dB) | 51.1 ± 21.2 | 40.8 ± 25.8 | 0.232 |
Average hearing threshold (dB) | 49.9 ± 22.5 | 39.6 ± 24.9 | 0.223 |
Binaural hearing impairment (%) | 34.8 ± 30.0% | 21.9 ± 29.6% | 0.206 |
Speech reception threshold (dB) | 47.0 ± 22.8 | 35.3 ± 26.7 | 0.196 |
Speech discrimination ability | 85.2 ± 18.9 | 86.1 ± 21.4 | 0.898 |
Hearing | 0.161 | ||
Unimpaired (threshold ≤ 25 dB) | 1 | 21 | |
Impaired (>25 dB) | 9 | 41 | |
Dementia | 0.036 * | ||
No | 1 | 30 | |
Yes | 9 | 32 | |
Parkinson’s disease | 0.095 | ||
No | 4 | 10 | |
Yes | 6 | 52 |
Mild PD n = 44 | Severe PD n = 14 | p-Value | |
---|---|---|---|
Age (years) | 64.5 ± 8.7 | 72.3 ± 7.4 | 0.003 ** |
Gender | 0.305 | ||
Male | 29 | 7 | |
Woman | 15 | 7 | |
Right-hearing threshold (dB) | 28.6 ± 16.8 | 46.5 ± 28.5 | 0.041 * |
Left-hearing threshold (dB) | 31.8 ± 20.2 | 52.9 ± 29.3 | 0.024 * |
Average hearing threshold (dB) | 30.3 ± 17.8 | 49.6 ± 28.3 | 0.028 * |
Binaural hearing impairment (%) | 11.2 ± 20.3% | 29.9 ± 34.9% | 0.076 |
Speech reception threshold (dB) | 25.7 ± 14.7 | 45.2 ± 28.8 | 0.029 * |
Speech discrimination ability | 93.0 ± 9.4% | 80.7 ± 27.0% | 0.118 |
Hearing | 0.006 ** | ||
Unimpaired (threshold ≤ 25 dB) | 21 | 1 | |
Impaired (>25 dB) | 23 | 13 | |
Dementia | 0.006 ** | ||
No | 26 | 2 | |
Yes | 18 | 12 | |
APOE ε4 allele | 5 | 1 | 1.000 |
No APOE ε4 allele | 39 | 13 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cha, C.-H.; Lin, T.-K.; Wu, C.-N.; Yang, C.-H.; Huang, Y.-W.; Hwang, C.-F. Relationship of Hearing Loss to Parkinson’s Disease, Dementia, and APOE Genotype in Adults. Medicina 2024, 60, 703. https://doi.org/10.3390/medicina60050703
Cha C-H, Lin T-K, Wu C-N, Yang C-H, Huang Y-W, Hwang C-F. Relationship of Hearing Loss to Parkinson’s Disease, Dementia, and APOE Genotype in Adults. Medicina. 2024; 60(5):703. https://doi.org/10.3390/medicina60050703
Chicago/Turabian StyleCha, Chih-Hung, Tsu-Kung Lin, Ching-Nung Wu, Chao-Hui Yang, Yi-Wen Huang, and Chung-Feng Hwang. 2024. "Relationship of Hearing Loss to Parkinson’s Disease, Dementia, and APOE Genotype in Adults" Medicina 60, no. 5: 703. https://doi.org/10.3390/medicina60050703